Arcadia Biosciences, Inc. (RKDA)
0.4726
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
0.4653
-0.01
(-1.54%)
After-Hours: 20:00
Arcadia Biosciences Net Income (Quarterly) : -6.266M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.266M |
| March 31, 2026 | -4.385M |
| December 31, 2025 | -1.336M |
| September 30, 2025 | 0.856M |
| June 30, 2025 | -4.458M |
| March 31, 2025 | 2.599M |
| December 31, 2024 | -4.037M |
| September 30, 2024 | -1.182M |
| June 30, 2024 | 1.85M |
| March 31, 2024 | -0.947M |
| December 31, 2023 | -0.452M |
| September 30, 2023 | -0.639M |
| June 30, 2023 | 3.155M |
| March 31, 2023 | -9.203M |
| December 31, 2022 | -3.18M |
| September 30, 2022 | -2.288M |
| June 30, 2022 | -3.797M |
| March 31, 2022 | -4.61M |
| December 31, 2021 | -9.557M |
| September 30, 2021 | -2.836M |
| June 30, 2021 | -5.422M |
| March 31, 2021 | 1.681M |
| December 31, 2020 | 8.608M |
| September 30, 2020 | -7.165M |
| Date | Value |
|---|---|
| June 30, 2020 | -9.894M |
| March 31, 2020 | 2.423M |
| December 31, 2019 | -6.311M |
| September 30, 2019 | -14.19M |
| June 30, 2019 | 4.238M |
| March 31, 2019 | -12.61M |
| December 31, 2018 | -0.646M |
| September 30, 2018 | 4.45M |
| June 30, 2018 | -6.669M |
| March 31, 2018 | -10.62M |
| December 31, 2017 | -2.96M |
| September 30, 2017 | -4.525M |
| June 30, 2017 | -4.006M |
| March 31, 2017 | -4.216M |
| December 31, 2016 | -5.708M |
| September 30, 2016 | -4.175M |
| June 30, 2016 | -4.551M |
| March 31, 2016 | -5.19M |
| December 31, 2015 | -3.857M |
| September 30, 2015 | -4.619M |
| June 30, 2015 | -3.677M |
| March 31, 2015 | -5.803M |
| December 31, 2014 | -1.988M |
| December 31, 2013 | -2.873M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Moolec Science SA | -- |
| Zivo Bioscience, Inc. | -0.5125M |
| PMGC Holdings, Inc. | -2.959M |
| Archer-Daniels-Midland Co. | 912.00M |
| Alico, Inc. | 1.567M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.443M |
| Total Expenses (Quarterly) | 7.709M |
| EPS Diluted (Quarterly) | -2.094 |
| Enterprise Value | -3.147M |
| Gross Profit Margin (Quarterly) | 43.73% |
| Profit Margin (Quarterly) | -434.2% |
| Earnings Yield | -963.0% |
| Normalized Earnings Yield | -780.64 |